Abstract:The reaction of the vanadyl ion (VO2+) with imidazole-4-carboxylic acid (Im4COOH), imidazole-2-carboxylic acid (Im2COOH) and methylimidazole-2-carboxylic acid (MeIm2COOH), respectively, in the presence of small bioligands (bL) [oxalate (Ox), lactate (Lact), citrate (Cit) and phosphate (Phos)] and high-molecular-weight (HMW) human serum proteins [albumin (HSA) and transferrin (hTf)] were studied in aqueous solution using potentiometric acid–base titrations. The species distribution diagrams for the high-molecular-mass (HMM) proteins with oxidovanadium(IV) under physiological pH were dominated by VO(HMM)2, VOL(HMM) for unsubstituted ligands (L− = Im4COO− and Im2COO−). However, for the N-substituted MeIm2COOH, the species distribution diagrams under physiological pH were dominated by VOL2, VO(HMM)2 and VO2L2(HMM). These species were further confirmed by LC-MS, MALDI-TOF-MS and EPR studies. The glucose-stimulated insulin secretion (GSIS) action of the complexes was investigated using INS-1E cells at a 1 μM concentration, which was established through cytotoxicity studies via the MTT assay. The neutral complexes, especially VO(MeIm2COO)2, showed promising results in the stimulation of insulin secretion than the cationic [VO(MeIm2CH2OH)2]2+ complex and the vanadium salt. Oxidovanadium(IV) complexes reduced insulin stimulation significantly under normoglycaemic levels but showed positive effects on insulin secretion under hyperglycaemic conditions (33.3 mM glucose media). The islets exposed to oxidovanadium(IV) complexes under hyperglycaemic conditions displayed a significant increase in the stimulatory index with 1.19, 1.75, 1.53, 1.85, 2.20 and 1.29 observed for the positive control (sulfonylurea:gliclazide), VOSO4, VO(Im4COO)2, VO(Im2COO)2, VO(MeIm2COO)2 and VO(MeIm2CH2OH)22+, respectively. This observation showed a potential further effect of vanadium complexes towards type 2 diabetes and has been demonstrated for the first time in this study.

The Anti-Diabetic Effects and Pharmacokinetic Profiles of Bis(maltolato)oxovanadium in Non-Diabetic and Diabetic Rats.

[Hypoglycemic Effects of Bis(maltolato)oxovanadium Administered by Different Routes Upon Diabetic Rats].

Synthesis And Anti-Diabetic Activity Of New N,N-Dimethylphenylenediamine-Derivatized Nitrilotriacetic Acid Vanadyl Complexes

Effective Control of Blood Glucose Status and Toxicity in Streptozotocin-Induced Diabetic Rats by Orally Administration of Vanadate in an Herbal Decoction

Pharmacodynamics and Pharmacokinetics of the Insulin-Mimetic Agent Vanadyl Acetylacetonate in Non-Diabetic and Diabetic Rats.

Synthesis, Characterization and Anti-Diabetic Therapeutic Potential of a New Benzyl Acid-Derivatized Kojic Acid Vanadyl Complex

A New Insulin-Enhancing Agent: [N,N '-Bis(4-Hydroxysalicylidene)-O-Phenylene-Diamine]Oxovanadium(Iv) And Its Permeability And Cytotoxicity

Vanadium compounds: New potential antidiabetic drugs

The Molecular Mechanisms and Rational Design of Anti-Diabetic Vanadium Compounds.

Is the Hypoglycemic Action of Vanadium Compounds Related to the Suppression of Feeding?

Bis(acetylacetonato)-oxovanadium(iv), bis(maltolato)-oxovanadium(iv) and sodium metavanadate induce antilipolytic effects by regulating hormone-sensitive lipase and perilipin via activation of Akt.

Biospeciation of Oxidovanadium(IV) Imidazolyl–Carboxylate Complexes and Their Action on Glucose-Stimulated Insulin Secretion in Pancreatic Cells

A Non-Toxic Binuclear Vanadium(IV) Complex as Insulin Adjuvant Improves the Glycemic Control in Streptozotocin-Induced Diabetic Rats

Electrophysiological Changes in Rat Ventricular Myocardium of Experimental Diabetes and Action of CVB-D

Synthesis, characterization and anti-diabetic therapeutic potential of novel aminophenol-derivatized nitrilotriacetic acid vanadyl complexes

Effects on the Bones of Vanadyl Acetylacetonate by Oral Administration: a Comparison Study in Diabetic Rats.

Insulin-enhancing Activity of a Dinuclear Vanadium Complex: 5-Chloro-salicylaldhyde Ethylenediamine Oxovanadium(v) and Its Permeability and Cytotoxicity.

[Hypoglycemic Effects of Sodium Metavanadate in Diabetic Mice and Its Effect on Glucose Phosphorylation].

Synthesis, Structures and Insulin-Like Activity of Oxidovanadium(v) Complexes with Aroylhydrazones and Ethylmaltol Mixed-Ligands

Dexamethasone-Induced Insulin Resistance Attenuation by Oral Sulfur–Oxidovanadium(IV) Complex Treatment in Mice

Surface Engineering Promoted Insulin-Sensitizing Activities of Sub-Nanoscale Vanadate Clusters through Regulated Pharmacokinetics and Bioavailability